Join us this Thursday, 2/27, for an exciting look at the next generation of blood-based predictive biomarkers for therapy selection.

Liquid-biopsy-derived Glycoproteomic Profiling as a Novel Means for Noninvasive Diagnosis of Ovarian Cancer

Get in touch